Fig. 1 · Structure
Documents & Downloads
Dazodalibep
Anti-CD40L Antibody
Dazodalibep is a non-antibody fusion protein that targets CD40L, effectively inhibiting co-stimulatory signals between various immune cells, including T cells, B cells, and antigen-presenting cells. Its ability to modulate immune responses positions Dazodalibep as a valuable tool for research in autoimmune diseases such as rheumatoid arthritis and Sjögren's syndrome. This reagent allows for the exploration of cellular and humoral responses within these disease contexts.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2245953-10-8 |
| Applications | Anti-CD40L Antibody |
| Molecular Weight | 87.82 kDa |
| Synonyms | MEDI 4920; VIB 4920 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.